Prostate Cancer Clinical Trials in Cleveland

Showing 241-260 of 329 trials

Improving Erectile Function and Quality of Life After Prostate Cancer Treatment

NCT01996852

This is a research study of erectile dysfunction (ED) in men diagnosed with prostate cancer. 144 patients and partners will participate in the study. The purpose of this study is to test a new treatment that combines a cognitive-behavioral intervention with medication and a vacuum constrictive device to treat ED. This new treatment consists of multiple therapeutic elements that enhance compliance with medical treatment and increase sexual activity through enhancement of the sensual pleasure of sex and partner support.

Prostate CancerErectile Dysfunction Following Radical ProstatectomyErectile Dysfunction Following Simple Prostatectomy+1 more

Case Comprehensive Cancer Center34 participantsStarted Jul 2013

Cleveland, Ohio, United States

UNKNOWNNA< 1 mile

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

NCT00772317

For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)

Recurrent Prostate Cancer

SonaCare Medical117 participantsStarted Jul 2008

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +13 more locations

Improving Erectile Function and Quality of Life After Prostate Cancer Treatment

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Prostate Cancer Trials in Other Cities

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Vidaza to Restore Hormone Thx Prostate

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Other Conditions in Cleveland